HEYU BIOLOGICAL TECHNOLOGY CORPORATION – Trademark Portfolio
Entity Type: 03
HEYU BIOLOGICAL TECHNOLOGY CORPORATION holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 2 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include HYBT. The owner is based in New York, NY.
1450 Broadway, 26th Floor
New York, NY 10018
Showing of trademarks Trademarks
Trademark Classifications
HEYU BIOLOGICAL TECHNOLOGY CORPORATION's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does HEYU BIOLOGICAL TECHNOLOGY CORPORATION have?
HEYU BIOLOGICAL TECHNOLOGY CORPORATION has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does HEYU BIOLOGICAL TECHNOLOGY CORPORATION file in?
HEYU BIOLOGICAL TECHNOLOGY CORPORATION files trademarks across 2 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are HEYU BIOLOGICAL TECHNOLOGY CORPORATION's most well-known trademarks?
HEYU BIOLOGICAL TECHNOLOGY CORPORATION's registered trademark portfolio includes well-known marks such as HYBT. These are among 2 currently registered trademarks in the portfolio.
What is HEYU BIOLOGICAL TECHNOLOGY CORPORATION's trademark registration success rate?
HEYU BIOLOGICAL TECHNOLOGY CORPORATION has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.